Home · Open Lab · Lot RGX-26-RGNX-1023
RGX-26-RGNX-1023Current
MOTS-C · 20 MG · Metabolic Research · COA NS-2026-05024

Release test results

99.678%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 20.12 mg
Related impurities (total)0.322%
Endotoxin<1.0 EU/mg
HPLC retention time4.69 min
MethodHPLC + LC-MS
ResultPass · meets spec

Lot record

CompoundMOTS-C
Presentation20 MG
Lot numberRGX-26-RGNX-1023
COA numberNS-2026-05024
Test date08 Sep 2026
Release date11 Sep 2026
Independent labNordicstar Labs
StatusCurrent

MOTS-C — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-RGNX-1023 this lot20 MGSep 8, 202699.678%Current
RGX-26-RGNX-67630 MGSep 8, 202699.737%Superseded
RGX-26-RGNX-77810 MGSep 7, 202699.592%Superseded
RGX-26-RGNX-77720 MGSep 7, 202699.630%Superseded
RGX-26-RGNX-102210 MGSep 6, 202699.640%Current
RGX-26-RGNX-67720 MGSep 6, 202699.744%Superseded
RGX-26-RGNX-77540 MGSep 6, 202699.699%Superseded
RGX-26-RGNX-102540 MGSep 5, 202699.754%Current
RGX-26-RGNX-67540 MGSep 5, 202699.592%Superseded
RGX-26-RGNX-77630 MGSep 4, 202699.706%Superseded
RGX-26-RGNX-102430 MGSep 3, 202699.716%Current
RGX-26-RGNX-67810 MGSep 2, 202699.668%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →